De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype (Q37342092)
Jump to navigation
Jump to search
scientific article published on 24 September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype |
scientific article published on 24 September 2016 |
Statements
1 reference
De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype (English)
1 reference
Alexander Hoischen
1 reference
Undiagnosed Diseases Network
1 reference
Vandana Shashi
1 reference
Loren D M Pena
1 reference
Katherine Kim
1 reference
Barbara Burton
1 reference
Maja Hempel
1 reference
Kelly Schoch
1 reference
Magdalena Walkiewicz
1 reference
Heather M McLaughlin
1 reference
Megan Cho
1 reference
Nicholas Stong
1 reference
Scott E Hickey
1 reference
Christine M Shuss
1 reference
Michael S Freemark
1 reference
Jane S Bellet
1 reference
Martha Ann Keels
1 reference
Melanie J Bonner
1 reference
Maysantoine El-Dairi
1 reference
Megan Butler
1 reference
Peter G Kranz
1 reference
Constance T R M Stumpel
1 reference
Sylvia Klinkenberg
1 reference
Karin Oberndorff
1 reference
Malik Alawi
1 reference
Rene Santer
1 reference
Slavé Petrovski
1 reference
Outi Kuismin
1 reference
Satu Korpi-Heikkilä
1 reference
Olli Pietilainen
1 reference
Palotie Aarno
1 reference
Mitja I Kurki
1 reference
Anna C Need
1 reference
David B Goldstein
1 reference
Fanny Kortüm
1 reference
24 September 2016
1 reference
1 reference
Identifiers
1 reference